Portal Biotechnologies Raises $9M, Navikenz Secures $7.5M in Life Sciences AI Funding
Portal Biotechnologies closes $9M funding round to expand cell engineering platform for drug discovery and cell therapy. Navikenz raises $7.5M seed round to scale AI transformation services focused on life sciences and pharmaceuticals.